Ponatinib and gossypol act in synergy to suppress colorectal cancer cells by modulating apoptosis/autophagy crosstalk and inhibiting the FGF19/FGFR4 axis
Objective: To evaluate the efficacy of ponatinib plus gossypol against colorectal cancer HCT-116 and Caco-2 cells. Methods: Cells were treated with ponatinib and/or gossypol at increasing concentrations to evaluate synergistic drug interactions by combination index. Cell viability, FGF19/FGFR4, and...
Main Authors: | Naglaa M El-Lakkany, Hadeel H Elkattan, Alaa E Elsisi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2023-01-01
|
Series: | Asian Pacific Journal of Tropical Biomedicine |
Subjects: | |
Online Access: | http://www.apjtb.org/article.asp?issn=2221-1691;year=2023;volume=13;issue=3;spage=131;epage=138;aulast=El-Lakkany |
Similar Items
-
FGF/FGFR Signaling in Hepatocellular Carcinoma: From Carcinogenesis to Recent Therapeutic Intervention
by: Yijun Wang, et al.
Published: (2021-03-01) -
Expression of FGF8, FGF18, and FGFR4 in Gastroesophageal Adenocarcinomas
by: Gerd Jomrich, et al.
Published: (2019-09-01) -
FGF/FGFR Pathways in Multiple Sclerosis and in Its Disease Models
by: Ranjithkumar Rajendran, et al.
Published: (2021-04-01) -
Targeting the Oncogenic FGF-FGFR Axis in Gastric Carcinogenesis
by: Jinglin Zhang, et al.
Published: (2019-06-01) -
Exploring the FGF/FGFR System in Ocular Tumors: New Insights and Perspectives
by: Alessandra Loda, et al.
Published: (2022-03-01)